However, no studies have been conducted to determine whether altered expression FMR1 and ASFMR1 isoforms are biomarkers of incipient FXTAS, particularly in relation to neurological and neuroanatomical changes. The gene discussed is FMR1-AS1; the disease is fragile X-associated tremor/ataxia syndrome.